Overview

Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura

Status:
COMPLETED
Trial end date:
2025-05-28
Target enrollment:
Participant gender:
Summary
This study aims to provide evidence on the efficacy, safety and acceptability of the new, chewable formulation of oxantel pamoate administered as a single dose or multiple doses, compared to mebendazole in children infected with T. trichiura. This study will involve children aged 2-12 years, since an infection with T. trichiura occurs often in children.
Phase:
PHASE2
Details
Lead Sponsor:
Jennifer Keiser
Collaborator:
Public Health Laboratory Ivo de Carneri
Treatments:
Mebendazole
oxantel pamoate